Literature DB >> 7861877

Defective maturation and function of antigen-presenting cells in type 1 diabetes.

A Jansen1, M van Hagen, H A Drexhage.   

Abstract

Macrophages and dendritic cells are important as antigen-presenting cells in the islet autoimmune response. We report decreased maturation of dendritic cells from blood monocytes of 61 patients with type 1 diabetes compared with 31 healthy controls (medians 26 and 35%, respectively, p = 0.0005). The dendritic cells also had reduced ability to cluster (96 and 124 clusters, respectively, p = 0.0005), and to stimulate autologous and allogeneic T cells. Because optimum antigen presentation is primarily required for tolerance induction rather than for immunisation, the defective maturation and function of diabetic dendritic cells might be the basis for disturbed activation of regulatory (suppressor) T cells.

Entities:  

Mesh:

Year:  1995        PMID: 7861877     DOI: 10.1016/s0140-6736(95)90586-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

Review 1.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Ocular manifestations and complications of pyogenic liver abscess.

Authors:  Yu-Meng Tan; Soon-Phaik Chee; Khee-Chee Soo; Pierce Chow
Journal:  World J Surg       Date:  2003-11-14       Impact factor: 3.352

3.  Impaired inflammatory responses to multiple toll-like receptor ligands in alveolar macrophages of streptozotocin-induced diabetic mice.

Authors:  Hideaki Yamasawa; Masayuki Nakayama; Masashi Bando; Yukihiko Sugiyama
Journal:  Inflamm Res       Date:  2012-01-07       Impact factor: 4.575

Review 4.  Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2012-12-28

5.  Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function.

Authors:  Donald Cheatem; Balaji B Ganesh; Eryn Gangi; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  Clin Immunol       Date:  2009-01-25       Impact factor: 3.969

6.  Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment.

Authors:  Tom L Van Belle; Therese Juntti; Jeanette Liao; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2009-12-09       Impact factor: 7.094

7.  Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D(3) and 1alpha-hydroxyvitamin D(3) on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet.

Authors:  J P Driver; O Foreman; C Mathieu; E van Etten; D V Serreze
Journal:  Clin Exp Immunol       Date:  2007-11-05       Impact factor: 4.330

8.  The cross-regulatory relationship between human dendritic and regulatory T cells and its role in type 1 diabetes mellitus.

Authors:  Hsuen-Wen Chang; Yen-Hung Chow; Pele Chong; Charles Sia
Journal:  Rev Diabet Stud       Date:  2007-08-10

9.  Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood.

Authors:  Xueqin Chen; Levi H C Makala; Yulan Jin; Diane Hopkins; Andy Muir; Nikhil Garge; Robert H Podolsky; Jin-Xiong She
Journal:  Clin Immunol       Date:  2008-09-30       Impact factor: 3.969

10.  Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette.

Authors:  John P Driver; Felix Scheuplein; Yi-Guang Chen; Alexandra E Grier; S Brian Wilson; David V Serreze
Journal:  Diabetes       Date:  2009-11-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.